BJ HEALTH (02389) announced its interim results, reporting a shareholder loss of HKD 31.797 million, an increase of 8.76% year-on-year.
Beijing Health (02389) announced its interim results for the six months ending June 30, 2026, reporting a revenue of HKD 30.279 million, a decrease of 60.46% year-on-year; the loss attributable to the owners of the parent company was HKD 31.797 million, an increase of 8.76% year-on-year; the loss per share was HKD 0.052.
BJ HEALTH (02389) announced its interim results for the six months ending June 30, 2026, reporting revenue of HKD 30.279 million, a year-on-year decrease of 60.46%; the loss attributable to the parent companys owners was HKD 31.797 million, an increase of 8.76% compared to the previous year; and the loss per share was HKD 0.052.
The announcement stated that the decline in operating revenue was mainly due to a significant reduction in sales revenue from healthcare and wellness products.
Related Articles
.png)
XINGDA INT'L (01899) released its interim results, with profit attributable to shareholders of 65 million yuan, a decrease of 67.3% compared to the same period last year.
EDDING GENOR (06998) Chairman Ni Xin plans to invest up to $1 million to increase his shareholding in the company.
JF SMARTINVEST (09636) 2026 Mid-term Performance Report: Practicing AI Technology's Comprehensive Strategy, Building a Closed Loop for Investment Advisory Services
XINGDA INT'L (01899) released its interim results, with profit attributable to shareholders of 65 million yuan, a decrease of 67.3% compared to the same period last year.
EDDING GENOR (06998) Chairman Ni Xin plans to invest up to $1 million to increase his shareholding in the company.
JF SMARTINVEST (09636) 2026 Mid-term Performance Report: Practicing AI Technology's Comprehensive Strategy, Building a Closed Loop for Investment Advisory Services
RECOMMEND
